Intensified tuberculosis case-finding in HIV-positive adults managed at ethiopian health centers: Diagnostic yield of xpert MTB/RIF compared with smear microscopy and liquid culture

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Balcha, Taye T ^a,b   Sturegård, Erik ^c   Winqvist, Niclas ^a,d   Skogmar, Sten ^a   Reepalu, Anton ^a   Jemal, Zelalem Habtamu ^e   Tibesso, Gudeta ^f   Schön, Thomas ^g,h   Björkman, Per ^a  

^a LUND UNIVERSITY   (Sweden)

^b FEDERAL MINISTRY OF HEALTH   (Ethiopia)

^c Clinical Microbiology Regional and University Laboratories   (Sweden)

^d Regional Department of Infectious Disease Control and Prevention   (Sweden)

^e Oromia Regional Health Bureau   (Ethiopia)

^f Department of Medicine   (Ethiopia)

^g LINKÖPING UNIVERSITY   (Sweden)

^h KALMAR COUNTY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BIOASSAY; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; ETHIOPIA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; LIQUID CULTURE; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDY; PUBLIC HEALTH SERVICE; RAPID TEST; SENSITIVITY AND SPECIFICITY; SPUTUM SMEAR; TUBERCULOSIS; ANTIBIOTIC RESISTANCE; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; DRUG EFFECTS; EPIDEMIOLOGY; GENETICS; MASS SCREENING; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MICROSCOPY; MOLECULAR DIAGNOSIS; MULTICENTER STUDY; NUCLEIC ACID AMPLIFICATION; PREVALENCE; PROCEDURES; REPRODUCIBILITY; SPUTUM;

ADULT; ANTIBIOTICS, ANTITUBERCULAR; BACTERIOLOGICAL TECHNIQUES; DRUG RESISTANCE, BACTERIAL; ETHIOPIA; FEMALE; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; MICROSCOPY; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PREVALENCE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RIFAMPIN; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULOSIS;

EID: 84899839132     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085478     Document Type: Article

References (45)

1. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R (2008) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 22: 1897-1908.
2. Gupta A, Nadkarni G, Yang W-T, Chandrasekhar A, Gupte N, et al. (2011) Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis. PLoS One 6: e28691.
3. Lawn SD, Kranzer K, Edwards DJ, McNally M, Bekker L-G, et al. (2010) Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy. AIDS 24: 1323-1328.
4. Moore D, Liechty C, Ekwaru P, Were W, Mwima G, et al. (2007) Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. AIDS 21: 713-719. (Pubitemid 46568628)
5. Mtei L, Matee M, Herfort O, Bakari M, Horsburgh CR, et al. (2005) High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania. Clin Infect Dis 40: 1500-1507. (Pubitemid 40628639)
6. Lawn SD, Wood R (2011) Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis. J Infect Dis 204 Suppl: S1159-67.
7. Lawn SD, Zumla AI (2011) Tuberculosis. Lancet 378: 57-72.
8. Koenig SP, Riviere C, Leger P, Joseph P, Severe P, et al. (2009) High mortality among patients with AIDS who received a diagnosis of tuberculosis in the first 3 months of antiretroviral therapy. Clin Infect Dis 48: 829-831.
9. Bock NN, Jensen PA, Miller B, Nardell E (2007) Tuberculosis infection control in resource-limited settings in the era of expanding HIV care and treatment. J Infect Dis 196 Suppl: S108-13. (Pubitemid 47206089)
10. Harries AD, Zachariah R, Corbett EL, Lawn SD, Santos-Filho ET, et al. (2010) The HIV-associated tuberculosis epidemic-when will we act? Lancet 375: 1906-1919.
11. Rangaka MX, Wilkinson RJ, Glynn JR, Boulle A, van Cutsem G, et al. (2012) Effect of Antiretroviral Therapy on the Diagnostic Accuracy of Symptom Screening for Intensified Tuberculosis Case Finding in a South African HIV Clinic. Clin Infect Dis 55: 1698-1706.
12. WHO (2012) policy on collaborative TB/HIV activities: guidelines for national programmes and other stakeholders. Geneva, Switzerland: World Health Organization.
13. Getahun H, Kittikraisak W, Heilig CM, Corbett EL, Ayles H, et al. (2011) Development of a Standardized Screening Rule for Tuberculosis in People Living with HIV in Resource-Constrained Settings: Individual Participant Meta-Analysis of Observational Studies. PLoS Med 8: e1000391.
14. Lawn SD, Brooks S V, Kranzer K, Nicol MP, Whitelaw A, et al. (2011) Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. PLoS Med 8: e1001067.
15. Cain KP, McCarthy KD, Heilig CM, Monkongdee P, Tasaneeyapan T, et al. (2010) An algorithm for tuberculosis screening and diagnosis in people with HIV. N Engl J Med 362: 707-716.
16. Bassett I V, Wang B, Chetty S, Giddy J, Losina E, et al. (2010) Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clin Infect Dis 51: 823-829.
17. Aparna S, Moorthy KVK, Gokhale S (2006) From microscopy centre to culture laboratory: a viable ride for mycobacteria. Int J Tuberc Lung Dis 10: 447-449.
18. WHO (2010) Roadmap for rolling out Xpert MTB/RIF for rapid diagnosis of TB and MDR TB. Geneva, Switzerland.
19. Helb D, Jones M, Story E, Boehme C, Wallace E, et al. (2009) Rapid Detection of Mycobacterium tuberculosis and Rifampin Resistance by Use of On-Demand, Near-Patient Technology. J Clin Microbiol 48: 229-237.
20. Steingart K, Sohn H, Schiller I, La K, Boehme, Catharina C, Pamela Nabeta DH, et al, et al. (2013) Xpert ® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults (Review). Cochrane Rev.
21. Ligthelm LJ, Nicol MP, Hoek KGP, Jacobson R, van Helden PD, et al. (2011) Xpert MTB/RIF for rapid diagnosis of tuberculous lymphadenitis from fine-needle-aspiration biopsy specimens. J Clin Microbiol 49: 3967-3970.
22. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, et al. (2011) Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 377: 1495-1505.
23. Theron G, Peter J, van Zyl-Smit R, Mishra H, Streicher E, et al. (2011) Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med 184: 132-140.
24. Lawn SD, Kerkhoff AD, Vogt M, Ghebrekristos Y, Whitelaw A, et al. (2012) Characteristics and Early Outcomes of Patients With Xpert MTB/RIF-Negative Pulmonary Tuberculosis Diagnosed During Screening Before Antiretroviral Therapy. Clin Infect Dis: 1-9.
25. Trébucq A, Enarson DA, Chiang CY, Deun A Van, Harries AD, et al. (2011) Xpert ® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how? Int J Tuberc Lung Dis 15: 1567-1571.
26. WHO/TDR/FIND (2006) Diagnostics for tuberculosis Global demand and market potential Diagnostics for tuberculosis Global demand and market potential, Geneva.
27. WHO (2012) Global Tuberculosis Report. Geneva, Switzerland
28. Datiko DG, Yassin M a, Chekol LT, Kabeto LE, Lindtjørn B (2008) The rate of TB-HIV co-infection depends on the prevalence of HIV infection in a community. BMC Public Health 8: 266.
29. Shah S, Demissie M, Lambert L, Ahmed J, Leulseged S, et al. (2009) Intensified tuberculosis case finding among HIV-Infected persons from a voluntary counseling and testing center in Addis Ababa, Ethiopia. J Acquir Immune Defic Syndr 50: 537-545.
30. Balcha TT, Jeppsson A (2010) Outcomes of antiretroviral treatment: a comparison between hospitals and health centers in Ethiopia. J Int Assoc Physicians Aids Care 9: 318-324.
31. Assefa Y, Kiflie A, Tekle B, Mariam DH, Laga M, et al. (2012) Effectiveness and acceptability of delivery of antiretroviral treatment in health centres by health officers and nurses in Ethiopia. J Health Serv Res Policy 17: 24-29.
32. Ministry of Health (2006) AIDS in Ethiopia. Available: http://www.etharc.org/aidsineth/publications/aidsineth6th-en.pdf.
33. Ministry of Health of Ethiopia (2008) Guidelines for Management of Opportunistic Infections and Antiretroviral Treatment in Adolescents and Adults in Ethiopia. Available: http://www.who.int/hiv/pub/guidelines/ethiopia-art.pdf.
34. Ministry of Health of Ethiopia (2012) Guidelines for clinical and programmatic management of tb, leprosy and tb/hiv in ethiopia fifth edition. Available: http://www.etharc.org/resources/download/finish/33/709.
35. WHO/International Union Against Tuberculosis and Lung Disease (2000) Technical guide: Sputum Examination for Tuberculosis by Direct Microscopy in Low-income Countries.
36. WHO (2013) Revised definitions and reporting framework for tuberculosis. Geneva, Switzerland.
37. Bassett I V, Wang B, Chetty S, Giddy J, Losina E, et al. (2010) Intensive Tuberculosis Screening for HIV-Infected Patients Starting Antiretroviral Therapy in Durban, South Africa. Clin Infect Dis 02114: 823-829.
38. WHO (2012) Global tuberculosis report. Geneva, Switzerland: World Health Organization.
39. Corbett EL, Macpherson P (2013) Tuberculosis screening in high human immunodeficiency virus prevalence settings: turning promise into reality. Int J Tuberc Lung Dis 17: 1125-1138.
40. Reid MJ a, Shah NS (2009) Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings. Lancet Infect Dis 9: 173-184.
41. Mugusi F, Villamor E, Urassa W, Saathoff E, Bosch RJ, et al. (2006) HIV co-infection, CD4 cell counts and clinical correlates of bacillary density in pulmonary tuberculosis. Int J Tuberc Lung Dis 10: 663-669. (Pubitemid 43845028)
42. Oni T, Burke R, Tsekela R, Bangani N, Seldon R, et al. (2011) High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening. Thorax 66: 669-673.
43. Schoch OD, Rieder P, Tueller C, Altpeter E, Zellweger J-P, et al. (2007) Diagnostic yield of sputum, induced sputum, and bronchoscopy after radiologic tuberculosis screening. Am J Respir Crit Care Med 175: 80-86. (Pubitemid 46105313)
44. Blakemore R, Story E, Helb D, Banada P, Owens MR, et al. (2010) Evaluation of the Analytical Performance of the Xpert MTB/RIF Assay Evaluation of the Analytical Performance of the Xpert MTB/RIF Assay †. J Clin Microbiol.
45. Williamson D a, Basu I, Bower J, Freeman JT, Henderson G, et al. (2012) An evaluation of the Xpert MTB/RIF assay and detection of false-positive rifampicin resistance in Mycobacterium tuberculosis. Diagn Microbiol Infect Dis 74: 207-209.